Imaging Agents: Market Research Report

Date: February 1, 2012
Pages: 450
Price:
US$ 4,500.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I7AE5BCAD07EN
Leaflet:

Download PDF Leaflet

Imaging Agents: Market Research Report
This report analyzes the worldwide markets for Imaging Agents in US$ Million by the following Product Segments - Contrast Media (X-Ray, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America.

Annual estimates and forecasts are provided for each region for the period 2009 through 2017.

Also, a six-year historic analysis is provided for these markets.

The report profiles 55 companies including many key and niche players such as AMAG Pharmaceuticals Inc., Bayer Schering Pharma AG, Bracco Group, Covidien, Daiichi Sankyo Company Limited, Eisai Co., Ltd, EUSA Pharma, Inc., GE Healthcare, Guerbet Group, and Lantheus Medical Imaging.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. Contrast Media
  X-Ray Contrast Media
  Magnetic Resonance Imaging (MRI) Contrast Media
  Ultrasound Contrast Media
B. Diagnostic Radiopharmaceuticals

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Industry Outlook
Medical Imaging Industry Under the Impact of Economic Downturn
Targeted Imaging – A Game Changer in the Making?
Developing Countries to Spur Growth
A Quick Primer On Imaging Agents
Growth Drivers
Growth Inhibitors
Changing Dynamics of Imaging Agents
Imaging Agents: Significant Growth Ahead
Rise of Non-Ionizing Imaging Techniques
Fusion Imaging Modalities: Greater Clinical Benefits
Radioactive Isotopes Utilized in PET & SPECT Imaging Procedures
Radiopharmaceuticals-An Exotic Tool
Nanomaterials Taking the Center Stage
Gadolinium Coated Nanoparticles- A Promising Imaging Agent
A Peek Into Pricing Dynamics
A Synoptic Overview
Pros & Cons
Positive Factors Driving Prices
Negative Factors Bearing Down on Prices
Reimbursements
“Under the Umbrella”
Europe
United States

2.MARKET TRENDS & ISSUES

Falling Prices Turn On the Heat
X-Ray Contrast Media: Declining Sector
MRI Contrast Media: Playing at Center Court
Impact Wielded by Ballooning MRI Practices
Ultrasound Contrast Media: A Rising Star in the Quadrant
Fledging Market Battles Teething Challenges
PET: A Prime Growth Driver for Radiopharmaceuticals
Nuclear Medicine: A Potential Growth Avenue for Radiopharmaceuticals
Select Cardiology and Oncology Radiopharmaceuticals

3.COMPETITION

Market Structure
Big Guns in the Emerging MRI Market
Bayer Schering Pharma AG: A Pioneering Developer of MRI Contrast Agents
Competitive Scenario

Table 1. Worldwide Imaging Agents Market (2009): Percentage Breakdown of Value Sales for Leading Players- GE Healthcare, Bracco, Covidien, Bayer Schering Pharma, and Others (includes corresponding Graph/Chart)
Table 2. X-ray Medical Contrast Media Market Worldwide (2009): Percentage Breakdown of Sales for GE Healthcare, Bracco, Covidien, Bayer Schering Pharma and Others (includes corresponding Graph/Chart)
Table 3. MRI Contrast Media Market Worldwide (2009): Percentage Breakdown of Sales for Bayer Schering Pharma, GE Healthcare, Bracco, Covidien and Others (includes corresponding Graph/Chart)
Table 4. Radiopharmaceutical Contrast Media Market Worldwide: Percentage Share of Leading Players for 2007 – GE Healthcare, Bristol-Myers Squibb, Mallinckrodt/ Covidien, MDS Nordion and Others (Revenue Share) (includes corresponding Graph/Chart)

4.TECHNOLOGY BREAKTHROUGHS

Molecular Imaging Agents: The Outer Limits
On Cards: Hyperpolarized Gases as Contrast Agents
Imaging Agents Make a Welcome Impact in the Field of Alzheimer’s Disease
Technetium-99m: A Breakthrough Contrast Agent for CNS Imaging
A New Imaging Agent for Radiopharmaceutical Scans
Multi-Modal Image Registration: Combating Contrast Medium Inconsistencies
Saline Flushes To Help Ensure Accurate Delivery of Contrast Agents

5.PRODUCT OVERVIEW

Contrast Agents
Contrast Media: How Do They Function?
Where Are They Used…?
Evolution of Contrast Media: A Profile
Bismuth Nitrate: Beginning of Contrast Agents
Imaging Agents: Significant Developments in the Last Fifty Years
Schering Develops First Intravenous Contrast Agent
MRI: Creating a New Era for Contrast Agents
A Peek into the Finer Points of Differences Among Contrast Media
Viscosity
Osmolality
Chemotoxicity
Second Generation Non-Ionic Contrast Agents: An Introduction
Choice of the Contrast Medium: A Weighty Decision
Factors affecting choice of Imaging Agents
Taxonomy
Types of Contrast Media
X-Ray Contrast Medium
First Generation High Osmolar Contrast Media
Second Generation Low Osmolar Contrast Media or LOCM

Table 5. Comparative Analysis of Structure of Non-ionic and ionic X-ray Contrast Media

MRI Contrast Medium
Role of Contrast Enhancement in MR Angiography (MRA)
MRI Contrast Agents for the Liver
Paramagnetic extracellular contrast agents
Hepatobiliary Gadolinium Chelates
Superparamagnetic Iron Oxide Particles
Ultrasound Contrast Medium
Ultrasonographic Contrast Media: What Are They?
Ultrasound Contrast Enhancement in Cardiology
Functionalities of Vascular Ultrasound Contrast Agents
Diagnostic Radiopharmaceuticals
Key Radioactive Isotopes used as Diagnostic Radiopharmaceuticals
A Delineate of Diagnostic Radiopharmaceuticals
Diagnostic Radiopharmaceuticals: A Technical Run-Through
Applications

6.A SEGMENTAL REVIEW

Contrast Media
Popular Brands of Contrast Agents
X-ray Contrast Media
Market Scenario
MRI Contrast Media
Market Scenario
Ultrasound Contrast Media
Market Overview
Competitive Scenario
Diagnostic Radiopharmaceuticals
Market Overview
Immunoconjugates
Market Overview

7.TECHNOLOGY DYNAMICS

Proprietary Technologies Making Significant In-Roads
Advanced Magnetics’ Proprietary Colloidal Superparamagnetic Particle Technology
Enzon’s Single Chain Antigen-Binding Technology
Immunomedics’ Antibody Technology
First Generation
Second Generation
Third Generation
NeoRx’s “Painting the Target” Technology
Stage - I
Stage - II
Stage - III
Gas Encapsulation Technology for Ultrasound Contrast Media
Pharmacyclics’ Texaphyrin Technology
Regulatory Bodies
Ultrasound Contrast Agents Are Drugs, Not Devices - Rules US FDA
Entry Barriers
Research Driven Markets
Highly Competitive Market
Economies of Scale
Substitutes in Agents Manufacturing
New X-ray Diagnostic Agents
Amide-based Macrocyclic Ligands - Potential MRI Agents
Gadolinium (III) Complexes - Potential MRI Contrast Agents
Metal-Containing Compounds Act As Potential Contrast Agents
Therapeutic Applications
Diagnostic Applications
Magnetic Gels as Potential MRI Contrast Agents
PFCs as Diagnostic Contrast Agents

8.PRODUCT LAUNCHES

GE Healthcare Receives FDA Approval for DaTscan for detecting Dopamine Transporters
Targeson Launches Targestar® P-HF
GE Healthcare Announces Phase II Study Results of Flutemetamol, the PET Imaging Agent for Brain Imaging
GE Healthcare Receives FDA Approval for Cysview, An Optical Imaging Agent for Cystoscopic Detection of Papillary Bladder Cancer
INER Develops Imaging Agents for Cerebral Blood Flow
Lantheus Medical Imaging Introduces Definity Ultrasound Contrast Imaging Agent in India
Sanochemia Pharmazeutika Completes DCP Phase of MRT Imaging Agent, to Introduce Within Major European Markets by 2011
Bayer Transfers Liver MRI Contrast Medium Resovist Injection to I’rom Pharmaceutical
GE Healthcare Re-Introduces Contrast Agent, OptisonTM
Lantheus Medical Imaging Introduces ABLAVAR™ in Canada
VisEn Introduces ProSense® 750 FAST and Neutrophil ElastaseTM 680 FAST
Bayer Works on Development of MR Contrast Agents for Breast Cancer Diagnosis
Lantheus Medical Imaging Introduces ABLAVAR™ MRA Imaging Agent
VisEn Introduces Cat B 680 FAST™ Imaging Agent
VisEn Medical Introduces GastroSense 750 Fluorescence Imaging Agent
VisEn Medical Unveils VivoTag® 645 Red Fluorescent Dye
VisEn Medical Launches VivoTag® 680 XL Fluorescent Dye
AMAG Pharmaceuticals Unveils Superparamagnetic Iron Oxide Nanopaticles
MabCure Unveils Monoclonal Antibodies
VisEn Medical Introduces ReninSense680TM FAST
VisEn Medical Introduces New VivoTag® 800 and OsteoSense® Imaging Agents
VisEn Medical Introduces Annexin-Vivo 750 Imaging Agent
VisEn Introduces New Fluorescence Molecular Imaging Agent, IntegriSense™ 750

9.RECENT INDUSTRY ACTIVITY

Covidien to Spin Off Pharma Business
University of Montana Receives Patents for Two New Brain Imaging Agents
Eli Lilly Acquires Avid Radiopharmaceuticals
GE Global Research Secures Multi-Year NIH Grant to Develop Nerve Imaging Agent and Imaging System
Agfa Healthcare Snaps Insight Agents
Nordion to Divest MDS Nordion S.A.
Sofie Biosciences Secures Funds for Research on Molecular PET Imaging Agents
Aposense Signs Collaboration Agreement With Roche
University of Washington to Collaborate with Cardinal Health for Advancement of Molecular Imaging
ImaginAb Joins Hand with GE Imanet for Developmental Drug Research
Cancer Targeted Technology Inks Agreement with Bayer Pharma for Cancer PET Imaging Agent
Lantheus Medical Imaging Wins Global Rights for Gadofosveset Trisodium
Avid Radiopharmaceuticals Partners with Siemens PETNET Solutions for Production of Florbetapir F 18
VisEn Expands Fluorescence Imaging Intellectual Patent Portfolio through Acquisition of Bayer Schering’s Portfolio
Cardinal Health Enters into Partnership with ProVision for Cyclotrons
Center for Diagnostic Imaging Sets up New Imaging Center
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL Biologics
Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement for Molybdenum-99
Lantheus Medical Imaging Purchases MS-325 Related Rights from EPIX Pharmaceuticals
GE Healthcare Inks Agreement with Nycomed
Photocure Secures Reimbursement Approval for Hexvix in Germany
Agfa HealthCare to Acquire Insight Agents
Eckert & Ziegler Disinvests FCI Contrast Media Business
Guerbet Signs Distribution Agreement with Draximage for its Nuclear Medicine Product Range
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL Biologics
Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement for Molybdenum-99
Lantheus Medical Imaging Purchases MS-325 Related Rights for Select Markets from EPIX Pharmaceuticals
MDS Nordion, TRIUMF and University of British Columbia Enter into Partnership
Alseres Pharmaceuticals Signs Agreement for Special Protocol Assessment of Altropane
Pharmalucence Wins Approval from FDA for Sestamibi Kit
Covidien Obtains Approval from Health Canada for Sestamibi Injection
MDS Nordion Commences Production of CardioGen-82

10.STRATEGIC CORPORATE DEVELOPMENTS IN PAST – A PERSPECTIVE BUILDER

Avista Capital Partners Acquires Bristol-Myers Squibb Medical Imaging
Amerinet Awards Contract to Bayer HealthCare
Bristol-Myers Squibb Medical Imaging Changes Name to Lantheus Medical Imaging
Bayer Schering Secures FDA Marketing Clearance for Primovist®
Bracco-Eisai Secures Approval for Iomeron® 350 and Iomeron® 350 Syringe for Use in Dynamic Liver CT
Covidien Signs Co-Marketing Deal with PETNET over Nuclear Medicine Therapies
EPIX Receives FDA Approval for Vasovist
GE Global and NCI Partner to Speed-up Development of Cancer and Heart Disease Diagnosing Nanoparticle Imaging Agents
Lantheus Wins Contract from PPP
Sanguine to Take over Rockland
Starpharma Holdings Enters into an Agreement with Unilever
GE Healthcare and Cardinal Health Enter Into a Deal
Jubilant to Take Over DRAXIS
MTTI and Bexion to Partner for Nanovesicle
Otsuka Takes over IPP
Wilex Inks Deal with IBA
Eusa Pharma Takes Over Cytogen
Bracco Group Acquires E-Z-EM
EPIX Pharmaceuticals to Resubmit New Drug Application (NDA) for Vasovist
Bayer Schering, FutureChem Ink Licensing Deal
NuView Radio Pharmaceuticals Inks Agreement for Non- Invasive Imaging Agent
Advanced Magnetics Inc Changes Name to AMAG Pharmaceuticals
Bracco Diagnostics Inks Agreement with HealthTrust Purchasing Group
Bracco Diagnostics Offers MRI Products to HealthTrust Purchasing Group
Bayer HealthCare Offers MRI Contrast Agent to HealthTrust
Bayer HealthCare Extends Contract with Premier
Bayer HealthCare Sets Off US Operations
Tyco Healthcare Renamed to Covidien Ltd
Covidien Offers Imaging Solutions to MedAssets Supply Chain Systems
Siemens, M.D. Anderson Cancer Center Set up Research Centre
Bayer, Berlex Merge Operations
AION Diagnostics Forays Pre-Clinical Imaging Agent Market
ART Acquires Alerion Biomedical
EPIX to Merge with Predix
Fujifilm Acquires Stake in Daiichi Radioisotope Laboratories
Bracco Diagnostics Inks Agreement with Amerinet
Vasovist receives Green Signal in Australia
AION Diagnostics Develops BioSilicon TM
Sonazoid Receives Import Approval

11.PRODUCT INTRODUCTIONS/INNOVATIONS – A HISTORIC PERSPECTIVE BUILDER

Insight Agents to Launch Generic Contrast Media Solutions In Europe
Researchers Develop First Biocompatible MRI Contrast Agent
Signalomics and Invitrogen Collaborate to Develop Nanocrystal Reagents
Schering AG Collaborates with Stanford University to Develop Molecular Imaging Agent
Schering and Avid to Develop Diagnostic Imaging Agents
US National Institutes of Health Develops two PET Imaging Agents

12.FOCUS ON SELECT PLAYERS

AMAG Pharmaceuticals, Inc. (USA)
Bayer Schering Pharma AG (Germany)
Bracco Group (Italy)
Covidien (USA)
Daiichi Sankyo Company Limited (Japan)
Eisai Co Ltd. (Japan)
EUSA Pharma, Inc. (UK)
GE Healthcare (UK)
Guerbet Group (France)
Lantheus Medical Imaging (USA)

13.GLOBAL MARKET PERSPECTIVE

Table 6. World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 7. World Historic Review for Imaging Agents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 8. World 15-Year Perspective for Imaging Agents by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 9. World Recent Past, Current & Future Analysis for Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 10. World Historic Review for Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 11. World 15-Year Perspective for Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 12. World Recent Past, Current & Future Analysis for Contrast Media by Product Segments – X-Ray, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 13. World Historic Review for Contrast Media by Product Segments – X-Ray, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 14. World 15-Year Perspective for Contrast Media by Product Segments - Percentage Breakdown of Dollar Sales for X-Ray, MRI and Ultrasound Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 15. World Recent Past, Current & Future Analysis for X-Ray Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 16. World Historic Review for X-ray Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 17. World 15-Year Perspective for X-Ray Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 18. World Recent Past, Current & Future Analysis for MRI Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 19. World Historic Review for MRI Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 20. World 15-Year Perspective for MRI Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 21. World Recent Past, Current & Future Analysis for Ultrasound Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 22. World Historic Review for Ultrasound Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 23. World 15-Year Perspective for Ultrasound Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 24. World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 25. World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 26. World 15-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. Market Analysis
  Outlook
  Imaging Centers Feel the Heat During Recession
  Growth Stimulants
  Dynamics of Pricing
  Diagnostic Radiopharmaceuticals
  Market Scenario
  Availability of Isotopes: A Tough Challenge
  Radiopharmaceuticals to Drive Growth
  Competitive Analysis – Imaging Market
  Reimbursement Issues
  Medicare
  Magnetic Resonance Imaging
  Regulatory Environment
  Provisions Regarding Off-Label Usage of Contrast Media
  Contrast Media
  X-ray Contrast Media
  MRI Contrast Media
  Market Scenario
  Managed Care Vs MRI Technology Diffusion
  Ultrasound Contrast Media
B. Market Analytics

Table 27. US Recent Past, Current & Future Analysis for Imaging Agents by Product Segment – Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 28. US Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 29. US 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

2.CANADA

A. Market Analysis
  Outlook
  Diagnostic Equipment Market
  LOCM Products Approved in Canada
B. Market Analytics

Table 30. Canadian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment- Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 31. Canadian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 32. Canadian 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

3.JAPAN

A. Market Analysis
  Outlook
  Reimbursement Issues
B. Market Analytics

Table 33. Japanese Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 34. Japanese Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 35. Japanese 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4.EUROPE

A. Market Analysis
  Outlook
  Trends
  Reimbursement
  Outsourcing of Imaging Diagnostics
  Distribution Structure
  Direct Sales
  License Agreements
  Distribution Agreements
  A Price Sensitive Market
  Macro Environment
  Germany
  France
  Spain & Italy
  Scandinavia
B. Market Analytics

Table 36. European Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region – France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 37. European Historic Review for Imaging Agents by Geographic Region – France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 38. European 15-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 39. European Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 40. European Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 41. European 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

    4A.FRANCE

      A. Market Analysis
        Growth Stimulants
      B. Market Analytics

Table 42. French Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 43. French Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 44. French 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) & Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

    4B.GERMANY

      Market Analytics

Table 45. German Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 46. German Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 47. German 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

    4C.ITALY

      Market Analytics

Table 48. Italian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 49. Italian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 50. Italian 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

    4D.THE UNITED KINGDOM

      Market Analytics

Table 51. UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 52. UK Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 53. UK 15-Year Perspective for Imaging Agents by Product Segment Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

    4E.SPAIN

      Market Analytics

Table 54. Spanish Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 55. Spanish Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 56. Spanish 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

    4F.RUSSIA

      Market Analytics

Table 57. Russian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment -Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 58. Russian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 59. Russian 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

    4G.REST OF EUROPE

      Market Analytics

Table 60. Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 61. Rest of Europe Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 62. Rest of Europe 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

5.ASIA-PACIFIC

A. Market Analysis
  MRI Market in Asia
  ANSTO: Leading the Radiopharmaceuticals Market
  India – A High Potential Market
B. Market Analytics

Table 63. Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 64. Asia-Pacific Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 65. Asia-Pacific 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

6.THE MIDDLE EAST

Market Analytics

Table 66. Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 67. Middle East Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 68. Middle East 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

7.LATIN AMERICA

A. Market Analysis
  Private Sector Boosts Healthcare Segment
B. Market Analytics

Table 69. Latin American Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 70. Latin American Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 71. Latin American 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 55 (including Divisions/Subsidiaries - 68)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Italy
Rest of Europe
Asia-Pacific (Excluding Japan)
Africa

Ask Your Question

Imaging Agents: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: